Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real‐World Analysis of the <scp>IMMUreal</scp> Cohort

Sequential therapy following atezolizumab and bevacizumab is feasible only for selected patients. However, preserving liver function seems crucial to optimising multi-line therapy and improving outcomes in advanced hepatocellular carcinoma.

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2025-04-04
DOI
https://doi.org/10.1111/apt.70090
Citations
4
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
5.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real‐World Analysis of the IMMUreal Cohort

Ignazio Piseddu, Florian Paul Reiter, Julia V. Mayerle, Ursula Ehmer et al.
4 citations
Alimentary Pharmacology & Therapeutics
Hepatocellular Carcinoma Treatment and Prognosis
5.29
article

Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real‐World Analysis of the IMMUreal Cohort

Ignazio Piseddu, Florian Paul Reiter, Julia V. Mayerle, Ursula Ehmer, Najib Ben Khaled, Michael T. Dill, Monika Rau, Hans Benno Leicht, Andreas Geier, Enrico Narciso De Toni, Matthias Pinter, Alexander Weich, Arne Kandulski, Bernard Hobeika, Valentina Zarka, Peter Schirmacher, Jens U. Marquardt, Liangtao Ye, Julia Schneider
article en
4 citations

Abstract

Sequential therapy following atezolizumab and bevacizumab is feasible only for selected patients. However, preserving liver function seems crucial to optimising multi-line therapy and improving outcomes in advanced hepatocellular carcinoma.

Alimentary Pharmacology & TherapeuticsVol. 61(11)
Sun Yat-sen University (CN), German Cancer Research Center (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), LMU Klinikum (DE), University Hospital Regensburg (DE), The Seventh Affiliated Hospital of Sun Yat-sen University (CN), National Center for Tumor Diseases (DE), Universitätsklinikum Würzburg (DE), Technical University of Munich (DE), Medical University of Vienna (AT), Ludwig-Maximilians-Universität München (DE), University of Lübeck (DE)
Good health and well-being
Openalex Percentile: Top 4%
Hepatocellular Carcinoma Treatment and Prognosis
5.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.